Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FDGK1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,494
Award facts
- Contract value 100% obligated
- $2,493.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,493.75 for Fasenra Pen 30 mg/ml on January 14, 2026. This firm fixed-price delivery order, issued without set-aside designation, is funded by the Defense Logistics Agency and will be performed at the contractor's Park Ridge facility, with an ultimate completion date of January 15, 2026. The award represents a routine pharmaceutical supply transaction supporting the federal military medical system's ongoing pharmaceutical needs.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The PPV-G GEN V program is a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. As a critical supplier within this framework, DMS Pharmaceutical Group has demonstrated substantial federal contracting performance across diverse therapeutic categories and product lines serving military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FDGK1?
SPE2DR26FDGK1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FDGK1 worth?
The government has obligated $2,494 on SPE2DR26FDGK1.
Is contract SPE2DR26FDGK1 an order under another contract?
Yes. SPE2DR26FDGK1 is a delivery order under SPE2DR25D9151, an indefinite delivery contract.
Was contract SPE2DR26FDGK1 competed?
The extent of competition for SPE2DR26FDGK1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award